Deep-pocketed investors have adopted a bullish approach towards Albemarle ALB, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ALB usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Albemarle. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 66% leaning bullish and 33% bearish. Among these notable options, 3 are puts, totaling $112,457, and 6 are calls, amounting to $619,234.
Projected Price Targets
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $110.0 and $200.0 for Albemarle, spanning the last three months.
Volume & Open Interest Trends
In today's trading context, the average open interest for options of Albemarle stands at 1252.57, with a total volume reaching 2,129.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Albemarle, situated within the strike price corridor from $110.0 to $200.0, throughout the last 30 days.
Albemarle Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|
ALB | CALL | SWEEP | BULLISH | 01/17/25 | $200.00 | $313.7K | 2.4K | 509 |
ALB | CALL | SWEEP | BEARISH | 02/16/24 | $120.00 | $135.6K | 3.1K | 1.0K |
ALB | PUT | SWEEP | BULLISH | 03/15/24 | $110.00 | $57.3K | 2.1K | 153 |
ALB | CALL | TRADE | BULLISH | 01/16/26 | $120.00 | $50.8K | 188 | 0 |
ALB | CALL | SWEEP | BULLISH | 03/01/24 | $121.00 | $40.7K | 62 | 74 |
About Albemarle
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the U.S. and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the U.S., Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
Albemarle's Current Market Status
- With a trading volume of 1,771,317, the price of ALB is down by -0.24%, reaching $115.5.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 2 days from now.
Expert Opinions on Albemarle
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $141.6.
- Reflecting concerns, an analyst from TD Cowen lowers its rating to Market Perform with a new price target of $130.
- An analyst from UBS has decided to maintain their Neutral rating on Albemarle, which currently sits at a price target of $137.
- An analyst from Citigroup has revised its rating downward to Neutral, adjusting the price target to $120.
- Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Albemarle with a target price of $191.
- An analyst from Mizuho persists with their Neutral rating on Albemarle, maintaining a target price of $130.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Albemarle with Benzinga Pro for real-time alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.